Dravite Therapeutics, Inc.
through Sep 3, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jul 28, 2026 · D/A | Sep 3, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $14,983,333 | $52,999,992 | $38,016,659 |
| Reported amount sold | $14,983,333 | $52,999,992 | $38,016,659 |
| Reported investor count | 8 | 11 | 3 |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001231919-26-000801 · Later SEC source: 0001231919-26-001141
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $52,999,992
- Reported amount sold
- $52,999,992
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (3)
-
0001231919-26-001141D · Sep 3, 2026 · OtherOffering: $52,999,992Sold: $52,999,992
-
0001231919-26-000801D/A · Jul 28, 2026 · OtherOffering: $14,983,333Sold: $14,983,333
-
0001231919-26-000695D · Jun 24, 2026 · OtherOffering: $14,983,333Sold: $14,983,333